Send Away Test for Oncotype DX Breast Recurrence Score

Official notice

Authority: Gloucestershire Hospitals NHS Foundation Trust (Central government)

ServicesAward procedure without prior publication of a call for competition

Sectors: Health & Social Care (85) Delivery: South West (UKK13)

Awarded value£214,650published contract · exc. VAT

Awarded 3 Feb 2026no call for competition

Awarded to Exact Sciences UK, Ltd.

What is being bought

Published requirement description

Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.

CPV: Pathology services

The lotProcurement structure

single lot · no lot value published

Lot #1This contract is to commission Exact Science to provide Oncotype DX Breast Recurrence…Awarded

This contract is to commission Exact Science to provide Oncotype DX Breast Recurrence Score which is a genomic assay that provides a personalised insight into an individual patients breast cancer biology. This contract has been awarded under Direct Award A The lifetime value of this contract is £214,650 The contract is in place from 1st July 2025 until 30th June 2026

Delivery: South West

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Services
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 3 Feb 2026, 14:27 GMT
Last source update: 3 Feb 2026, 14:27 GMT
FTS notice number: 2026/S 000-009502
Classification (CPV): Pathology services
Delivery area: South West (UKK13)
Official registry OCID: ocds-h6vhtk-061579 Find a Tender

Why no open competition: The procurement falls outside the scope of application of the directive
Published justification: Direct Award A due to there being only one provider of this service

Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provision of the Public Contracts Regulations 2015 do not apply to this award. Decision Makers involved were Siobhan Taylor, Lead Clinical Scientist, Kelly Attwood, Contracts Manager There were no conflicts of interests declared.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £214,6501 contract exc. VAT

Bids received 1

Contracts signed 1latest 3 Feb 2026

Awarded to	Value	Date	Status
Exact Sciences UK, Ltd.	£214,650 †	—	Awarded

Contracts

Contract 009502-2026-1 · Exact Sciences UK, Ltd.
Signed
3 Feb 2026
Value
£214,650
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authority & participating public bodies

Gloucestershire Hospitals NHS Foundation Trust

Contracting authorityCentral GovernmentBody governed by public lawHealth Alexandra House, Cheltenham General Hospital, Sandford Road, Gloucester, South West, GL53 7ANContact name, email

Bidders & participating suppliers

1 commercial party on the notice

Exact Sciences UK, Ltd.Awarded supplier07484560 Scott House - The Concourse Waterloo Station London, London, London, SE1 7LYContact email, phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.